Stockreport

CORRECTION -- AEON Biopharma Announces Redemption of Public Warrants

AEON Biopharma, Inc. Class A  (AEON) 
PDF IRVINE, Calif., March 30, 2024 (GLOBE NEWSWIRE) -- Regarding a release issued under the same headline on March 29, 2024 by AEON Biopharma, Inc. (NYSE: AEON; AEON.WS), [Read more]